Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Michael Atkins, MD, of Georgetown University, Washington, DC, discusses the current key research priorities for renal cell carcinoma (RCC) . Speaking at the 2019 Genitourinary Cancers Symposium, held in San Francisco, CA, Dr Atkins highlights the necessity of characterizing reliable biomarkers for developing effective treatments against RCC.